Max Healthcare Institute Limited

NSEI:MAXHEALTH Stok Raporu

Piyasa değeri: ₹1.1t

Max Healthcare Institute Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Max Healthcare Institute kazanç ve gelirin sırasıyla yıllık 29.5% ve 25.9% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 29% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 16.6% olacağı tahmin edilmektedir.

Anahtar bilgiler

29.5%

Kazanç büyüme oranı

29.0%

EPS büyüme oranı

Healthcare kazanç büyümesi26.5%
Gelir büyüme oranı25.9%
Gelecekteki özkaynak getirisi16.6%
Analist kapsamı

Good

Son güncelleme17 Oct 2024

Gelecekteki son büyüme güncellemeleri

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 03
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Recent updates

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Jul 18
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Jun 21
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Apr 14
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Mar 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 03
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Jan 08
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

Dec 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Oct 26
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Sep 20
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Jul 07
Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Jun 19
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

Apr 11
Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Mar 15
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Feb 22
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Nov 22
Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Oct 26
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Jul 15
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Mar 09
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Nov 24
Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Kazanç ve Gelir Büyüme Tahminleri

NSEI:MAXHEALTH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/2027119,22623,29814,06426,43413
3/31/2026101,95419,8148,48422,60319
3/31/202580,11014,9696,74718,24619
9/30/202459,97010,5902,64913,125N/A
6/30/202456,64010,538N/AN/AN/A
3/31/202454,06010,5763,35911,218N/A
12/31/202351,97610,570N/AN/AN/A
9/30/202350,0449,9017,14111,564N/A
6/30/202347,80711,708N/AN/AN/A
3/31/202345,62611,0359,48512,841N/A
12/31/202242,7999,763N/AN/AN/A
9/30/202241,1439,4373,8739,507N/A
6/30/202239,9766,310N/AN/AN/A
3/31/202239,3666,0511,8727,405N/A
12/31/202137,9785,510N/AN/AN/A
9/30/202136,1934,5161,4863,086N/A
6/30/202132,4863,236N/AN/AN/A
3/31/202125,080-1,375-61,179N/A
12/31/202027,772-1,177N/AN/AN/A
9/30/202022,487-2,1343,0243,911N/A
6/30/202014,849-2,681N/AN/AN/A
3/31/202010,590590-130771N/A
12/31/201910,081268N/AN/AN/A
9/30/201918,609720N/AN/AN/A
6/30/201917,719360N/AN/AN/A
3/31/201916,939-30-268890N/A
6/30/201817,053-704N/AN/AN/A
3/31/201817,303-302N/A822N/A
3/31/201716,085-14N/A1,561N/A
3/31/201614,343-180N/A7,225N/A
3/31/20157,896-381N/A387N/A
3/31/20149,445-646N/A732N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: MAXHEALTH 'nin tahmini kazanç büyümesi (yıllık 29.5% ) tasarruf oranının ( 6.7% ) üzerindedir.

Kazançlar ve Piyasa: MAXHEALTH şirketinin kazançlarının (yıllık 29.5% ) Indian pazarından (yıllık 17.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: MAXHEALTH şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: MAXHEALTH şirketinin gelirinin (yıllık 25.9% ) Indian pazarından (yıllık 10.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: MAXHEALTH şirketinin gelirinin (yıllık 25.9% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: MAXHEALTH 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16.6 %).


Büyüyen şirketleri keşfedin